Gene · 5338
Papers1,399
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,399
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phospholipase D2 acts upstream of PI4P 5-kinases in the response of neurons to extracellular viscosity. | iScience | 2026 | 42699044 | PubTator, text mining | PubMed |
| Metabolic Heterogeneity Across Heart Failure Subtypes Defined by Integrative Multi-Omics Analysis. | J Cardiovasc Transl Res | 2026 | 42380371 | PubTator, text mining | PubMed |
| PLD1 and PLD2 promote an immunosuppressive tumor microenvironment via CCL19-dependent macrophage polarization and PD-L1 induction. | Exp Mol Med | 2026 | 42243532 | PubTator, text mining | PubMed |
| The enigmatic role of tumor dormancy cells in gynecologic cancers. | Front Immunol | 2026 | 42220495 | PubTator, text mining | PubMed |
| Involvement of TRPA1 in Necrosis of Melanoma Cells via Phospholipase D1. | Cells | 2026 | 42121861 | PubTator, text mining | PubMed |
| Cell Cycle Control of Nuclear Metabolism Couples Phosphatidylinositol Signaling to Histone Methylation. | Adv Sci (Weinh) | 2026 | 42011901 | PubTator, text mining | PubMed |
| Global molecular landscape of early MASLD progression in human obesity. | Elife | 2026 | 41870035 | PubTator, text mining | PubMed |
Corrigendum to 'Optimizing functional recovery after acute ischemic stroke through intensity and frequency of rehabilitation: The critical role of HIF-1α/PLD2/mTOR signaling mechanisms' [Experimental Neurology 397 (2026) 115568]. | Exp Neurol | 2026 | 41794599 | PubTator, text mining | PubMed |
| Exosomes: Roles and Therapeutic Potential in Pain. | Biomedicines | 2026 | 41751313 | PubTator, text mining | PubMed |
| Functionalized Biomaterials in the Investigation of the Effects of Fluid Shear Forces in the Immune Regulation of Cancer Progression and Metastasis. | J Funct Biomater | 2026 | 41745543 | PubTator, text mining | PubMed |
| Exosome Augmentation Technologies for Drug Delivery and Disease Treatment: A Review. | Biomater Res | 2026 | 41728072 | PubTator, text mining | PubMed |
| From lipid switch to tissue repair: how resolvins reprogram macrophage polarization and function. | Immunometabolism (Cobham) | 2026 | 41625186 | PubTator, text mining | PubMed |
| Shielding retinal pigment epithelium cells from high glucose-induced oxidative stress: the protective effect of phospholipase D (PLD) pathway inhibition. | Biochim Biophys Acta Mol Cell Res | 2026 | 41617127 | PubTator, text mining | PubMed |
| Astragaloside IV Alleviates Colorectal Cancer Metastases by Regulating RALY/PLD2 Axis and Inhibiting Tumoral Exosome Biogenesis. | Phytother Res | 2026 | 41449865 | PubTator, text mining | PubMed |
| Extracellular vesicles in cancer immunotherapy: Therapeutic, challenges and clinical progress. | Asian J Pharm Sci | 2025 | 41809263 | PubTator, text mining | PubMed |
| Oleate activates PLD2 lipase and GEF activity by modulating membrane microdomain dynamics via S-acylation. | J Lipid Res | 2025 | 41223946 | PubTator, text mining | PubMed |
| Phospholipase D2 regulation by transcription factor FOXA1 promotes the drug resistance of vemurafenib in melanoma cells. | Biochem Pharmacol | 2025 | 41110487 | PubTator, text mining | PubMed |
| Exploring therapeutic targets for hepatocellular carcinoma through druggable genes. | Medicine (Baltimore) | 2025 | 41029168 | PubTator, text mining | PubMed |
| Golgi retention of KIT in gastrointestinal stromal tumour cells is phospholipase D activity-dependent. | Sci Rep | 2025 | 40770227 | PubTator, text mining | PubMed |
| Phospholipase D2: A biomarker implicated in various pancreatic diseases beyond acute pancreatitis. | World J Gastroenterol | 2025 | 40741474 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5338/papers